LTC2201012I2 - - Google Patents

Info

Publication number: LTC2201012I2
Authority: LT; Lithuania

Application number

LTPA2024532C

Other languages

Lithuanian (lt)

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-11

Filing date

2024-11-13

Publication date

2025-12-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40251789&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTC2201012(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2024-11-13 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2024-12-10 Publication of LTPA2024532I1 publication Critical patent/LTPA2024532I1/lt

2025-12-10 Publication of LTC2201012I2 publication Critical patent/LTC2201012I2/lt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

LTPA2024532C 2007-10-11 2024-11-13 LTC2201012I2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US97919207P	2007-10-11	2007-10-11
US4786208P	2008-04-25	2008-04-25
PCT/GB2008/050925 WO2009047563A1 (en)	2007-10-11	2008-10-09	Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors

Publications (2)

Publication Number	Publication Date
LTPA2024532I1 LTPA2024532I1 (en)	2024-12-10
LTC2201012I2 true LTC2201012I2 (en)	2025-12-10

Family

ID=40251789

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTPA2024532C LTC2201012I2 (en)	2007-10-11	2024-11-13

Country Status (43)

Country	Link
US (8)	US8101623B2 (en)
EP (1)	EP2201012B1 (en)
JP (2)	JP4705695B2 (en)
KR (1)	KR101494734B1 (en)
CN (1)	CN101861321B (en)
AR (1)	AR068846A1 (en)
AU (1)	AU2008309383B2 (en)
BR (1)	BRPI0818533B8 (en)
CA (1)	CA2701057C (en)
CL (1)	CL2008003023A1 (en)
CO (1)	CO6270328A2 (en)
CR (1)	CR11359A (en)
CU (1)	CU23886B1 (en)
CY (2)	CY1116929T1 (en)
DK (1)	DK2201012T3 (en)
DO (1)	DOP2010000103A (en)
EA (1)	EA018512B1 (en)
ES (1)	ES2522365T3 (en)
FI (1)	FIC20240039I1 (en)
FR (1)	FR24C1046I2 (en)
GT (1)	GT201000082A (en)
HN (1)	HN2010000653A (en)
HR (1)	HRP20140807T1 (en)
HU (1)	HUS2400038I1 (en)
IL (1)	IL204721A (en)
LT (1)	LTC2201012I2 (en)
ME (1)	ME01999B (en)
MX (1)	MX2010003927A (en)
MY (1)	MY150059A (en)
NI (1)	NI201000050A (en)
NL (1)	NL301299I2 (en)
NO (1)	NO2024050I1 (en)
NZ (1)	NZ585261A (en)
PE (2)	PE20130152A1 (en)
PL (1)	PL2201012T3 (en)
PT (1)	PT2201012E (en)
RS (1)	RS53552B1 (en)
SA (1)	SA08290625B1 (en)
SI (1)	SI2201012T1 (en)
TW (1)	TWI453021B (en)
UY (1)	UY31384A1 (en)
WO (1)	WO2009047563A1 (en)
ZA (1)	ZA201002318B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY179032A (en)	2004-10-25	2020-10-26	Cancer Research Tech Ltd	Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
WO2007125321A2 (en)	2006-04-25	2007-11-08	Astex Therapeutics Limited	Purine and deazapurine derivatives as pharmaceutical compounds
JP5339291B2 (en) *	2006-08-10	2013-11-13	オンコセラピー・サイエンス株式会社	Breast cancer-related genes and polypeptides
BRPI0818533B8 (en)	2007-10-11	2021-05-25	Astrazeneca Ab	compound, pharmaceutical composition, use of a compound, and, process for preparing a compound
WO2011002772A1 (en) *	2009-06-29	2011-01-06	Oncotherapy Science, Inc.	Imidazopyridine derivatives and pbk inhibitors containing the same
GB201020161D0 (en)	2010-11-26	2011-01-12	Almac Discovery Ltd	Pharmaceutical compounds
PL2651417T3 (en)	2010-12-16	2017-08-31	Calchan Limited	Ask1 inhibiting pyrrolopyrimidine derivatives
BR112013017722A2 (en)	2011-01-11	2016-07-12	Glaxosmithkline Llc	combination
ME03589B (en) *	2011-04-01	2020-07-20	Astrazeneca Ab	THERAPEUTIC TREATMENT
MX367640B (en) *	2011-11-30	2019-08-29	Astrazeneca Ab	Combination treatment of cancer.
AU2013204533B2 (en)	2012-04-17	2017-02-02	Astrazeneca Ab	Crystalline forms
US9156831B2 (en)	2013-01-23	2015-10-13	Astrazeneca Ab	Chemical compounds
EP2815749A1 (en)	2013-06-20	2014-12-24	IP Gesellschaft für Management mbH	Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
AU2014293013A1 (en)	2013-07-26	2016-03-17	Race Oncology Ltd.	Combinatorial methods to improve the therapeutic benefit of bisantrene
JP6295578B2 (en) *	2013-09-30	2018-03-20	凸版印刷株式会社	Reaction vessel, nucleic acid analyzer, and nucleic acid analysis method
MX2016004267A (en) *	2013-10-01	2016-07-08	Novartis Ag	Combination.
WO2015123424A1 (en)	2014-02-13	2015-08-20	Incyte Corporation	Cyclopropylamines as lsd1 inhibitors
US9527835B2 (en)	2014-02-13	2016-12-27	Incyte Corporation	Cyclopropylamines as LSD1 inhibitors
EP3392244A1 (en)	2014-02-13	2018-10-24	Incyte Corporation	Cyclopropylamines as lsd1 inhibitors
LT3105218T (en)	2014-02-13	2019-12-10	Incyte Corp	Cyclopropylamines as lsd1 inhibitors
KR102518994B1 (en) *	2014-05-28	2023-04-05	아스트라제네카 아베	Processes for the preparation of azd5363 and novel intermediate used therein
WO2016007736A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Imidazopyrazines as lsd1 inhibitors
WO2016007731A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Imidazopyridines and imidazopyrazines as lsd1 inhibitors
US9758523B2 (en)	2014-07-10	2017-09-12	Incyte Corporation	Triazolopyridines and triazolopyrazines as LSD1 inhibitors
WO2016007722A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines and triazolopyrazines as lsd1 inhibitors
EA201792205A1 (en)	2015-04-03	2018-02-28	Инсайт Корпорейшн	HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
DK3334709T3 (en)	2015-08-12	2025-02-03	Incyte Holdings Corp	SALTS OF AN LSD1 INHIBITOR
TW201726140A (en) *	2015-09-17	2017-08-01	瑞典商阿斯特捷利康公司	Novel biomarkers and methods of treating cancer
CA3021678A1 (en)	2016-04-22	2017-10-26	Incyte Corporation	Formulations of an lsd1 inhibitor
US10968200B2 (en)	2018-08-31	2021-04-06	Incyte Corporation	Salts of an LSD1 inhibitor and processes for preparing the same
WO2021041348A1 (en)	2019-08-26	2021-03-04	Arvinas Operations, Inc.	Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders
DK4054582T3 (en)	2019-11-04	2025-12-01	Astrazeneca Ab	THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB FOR THE TREATMENT OF B-CELL MALIGNANTS
JP2023520140A (en) *	2020-03-17	2023-05-16	江蘇恒瑞医薬股▲ふん▼有限公司	Fused bicyclic derivative, its preparation method and its pharmaceutical application
WO2022147519A1 (en) *	2021-01-04	2022-07-07	Teva Pharmaceuticals International Gmbh	Solid state forms of capivasertib and process for preparation thereof
CN116925080B (en) *	2022-03-29	2025-12-12	杭州健崃生物科技有限公司	Compounds as Akt protein kinase inhibitors, their preparation methods and uses
CN119278041A (en)	2022-03-31	2025-01-07	阿斯利康(瑞典)有限公司	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in combination with AKT inhibitors for the treatment of cancer
CN114601836B (en) *	2022-04-12	2022-12-06	四川大学华西医院	Application of AKT inhibitor in preparation of medicine for treating breast cancer
WO2024083716A1 (en)	2022-10-17	2024-04-25	Astrazeneca Ab	Combinations of a serd for the treatment of cancer
JP2025539034A (en)	2022-11-11	2025-12-03	アストラゼネカ・アクチエボラーグ	Combination Therapies for the Treatment of Cancer
WO2024104561A1 (en)	2022-11-15	2024-05-23	Astrazeneca Ab	Therapeutic combinations of capivasertib and venetoclax
CR20250538A (en)	2023-05-26	2026-04-21	Astrazeneca Ab	Harmaceutical compositions
JP2026518466A (en)	2023-06-02	2026-06-08	アルビナス・オペレーションズ・インコーポレイテッド	Combination of estrogen receptor degraders and AKT inhibitors
WO2025176877A1 (en)	2024-02-22	2025-08-28	Astrazeneca Ab	Therapeutic combination of an akt inhibitor, a bcl-2 inhibitor, and an anti-cd20 antibody
WO2025238662A1 (en) *	2024-05-15	2025-11-20	Msn Laboratories Private Limited, R&D Center	Improved process for the preparation of 4-amino-n-[(1s)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide and its salts
WO2026057582A1 (en)	2024-09-10	2026-03-19	Astrazeneca Ab	Therapeutic combinations of an akt inhibitor, a bcl-2 inhibitor, and a glucocorticoid
CN122234059A (en) *	2024-12-12	2026-06-19	安礼特（上海）医药科技有限公司	Carpicrite salt type and its preparation method

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL297170A (en)	1963-04-04	1900-01-01
GB9312853D0 (en)	1993-06-22	1993-08-04	Euro Celtique Sa	Chemical compounds
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
CA2242425C (en)	1996-02-13	2006-07-18	Zeneca Limited	Quinazoline derivatives as vegf inhibitors
NZ331191A (en)	1996-03-05	2000-03-27	Zeneca Ltd	4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
EP0944388A4 (en)	1996-04-03	2001-08-16	Merck & Co Inc	FARNESYL PROTEIN TRANSFERASE INHIBITORS
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
ES2284200T3 (en)	1997-02-12	2007-11-01	Electrophoretics Limited	PROTEINAL MARKERS FOR LUNG CANCER AND USE OF THE SAME.
US6432947B1 (en)	1997-02-19	2002-08-13	Berlex Laboratories, Inc.	N-heterocyclic derivatives as NOS inhibitors
GB9714249D0 (en)	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
WO1999007703A1 (en)	1997-08-05	1999-02-18	Pfizer Products Inc.	4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
US6162804A (en)	1997-09-26	2000-12-19	Merck & Co., Inc.	Tyrosine kinase inhibitors
AU4231299A (en)	1998-06-04	1999-12-20	Abbott Laboratories	Cell adhesion-inhibiting antinflammatory compounds
PA8474101A1 (en)	1998-06-19	2000-09-29	Pfizer Prod Inc	PYROLEUM [2,3-D] PIRIMIDINE COMPOUNDS
US6262066B1 (en)	1998-07-27	2001-07-17	Schering Corporation	High affinity ligands for nociceptin receptor ORL-1
GB9900334D0 (en)	1999-01-07	1999-02-24	Angiogene Pharm Ltd	Tricylic vascular damaging agents
GB9900752D0 (en)	1999-01-15	1999-03-03	Angiogene Pharm Ltd	Benzimidazole vascular damaging agents
EE05345B1 (en)	1999-02-10	2010-10-15	Astrazeneca Ab	Quinazoline derivatives as inhibitors of angiogenesis
HK1045306A1 (en)	1999-06-03	2002-11-22	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
PT1244647E (en)	1999-11-05	2006-10-31	Astrazeneca Ab	QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS
US7160890B2 (en)	1999-12-02	2007-01-09	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A3 receptor and uses thereof
HRP20020751B1 (en)	2000-02-15	2011-01-31	Sugen	PYROMOM SUBSTITUTED 2-INDOLINONES AS PROTEIN KINASE INHIBITORS
BR0111230A (en)	2000-05-31	2003-06-10	Astrazeneca Ab	Compound, and, use and process for the preparation thereof
UA73993C2 (en)	2000-06-06	2005-10-17	Астразенека Аб	Quinazoline derivatives for the treatment of tumours and a pharmaceutical composition
OA12292A (en)	2000-06-26	2003-11-11	Pfizer Prod Inc	PyrroloÄ2,3-dÜpyrimidine compounds as immunosuppressive agents.
KR20030014425A (en)	2000-07-07	2003-02-17	앤지오젠 파마슈티칼스 리미티드	Colchinol derivatives as vascular damaging agents
EE200300015A (en)	2000-07-07	2004-10-15	Angiogene Pharmaceuticals Limited	Colchinol derivatives as inhibitors of angiogenesis
KR100602929B1 (en)	2000-08-31	2006-07-20	에프. 호프만-라 로슈 아게	Quinazolin derivatives as alpha-1 adrenergic antagonists
BR0115847A (en)	2000-12-01	2004-02-25	Osi Pharm Inc	Adenosine Receptor Specific Compounds a1, a2a, and a3 and Uses
US6680324B2 (en)	2000-12-01	2004-01-20	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en)	2000-12-01	2004-01-06	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A3 receptor and uses thereof
JP2004532234A (en) *	2001-04-27	2004-10-21	バーテックス　ファーマシューティカルズ　インコーポレイテッド	Triazole-derived kinase inhibitors and uses thereof
DE60305446T4 (en)	2002-01-07	2009-07-09	Eisai R&D Management Co., Ltd.	DESAZAPURINE AND ITS USE
TW200403058A (en)	2002-04-19	2004-03-01	Bristol Myers Squibb Co	Heterocyclo inhibitors of potassium channel function
DK1522314T3 (en)	2002-06-26	2014-05-26	Ono Pharmaceutical Co	Remedies for diseases caused by vascular contraction or enlargement
US20040138238A1 (en)	2002-08-08	2004-07-15	Dhanoa Dale S.	Substituted aminopyrimidine compounds as neurokinin antagonists
US20030139427A1 (en)	2002-08-23	2003-07-24	Osi Pharmaceuticals Inc.	Bicyclic pyrimidinyl derivatives and methods of use thereof
WO2004021979A2 (en)	2002-09-06	2004-03-18	Smithkline Beecham Corporation	PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS
US20060159617A1 (en)	2002-11-08	2006-07-20	Ashfaq Mahmood	Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors
AU2003302657B8 (en)	2002-12-04	2009-12-03	Eisai R&D Management Co., Ltd.	Fused 1,3-dihydroimidazole ring compounds
EP1444982A1 (en)	2003-02-06	2004-08-11	Merckle Gmbh	The use of purine derivatives as selective kinase inhibitors
MXPA05009722A (en)	2003-03-10	2006-03-09	Schering Corp	Heterocyclic kinase inhibitors: methods of use and synthesis.
AU2004232392A1 (en)	2003-04-21	2004-11-04	Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky	(Purin-6-yl) amino acid and production method thereof
FR2856685B1 (en)	2003-06-25	2005-09-23	Merck Sante Sas	THIAZOLYLPIPERIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2005020921A2 (en)	2003-08-29	2005-03-10	Exelixis, Inc.	C-kit modulators and methods of use
WO2005044181A2 (en)	2003-09-09	2005-05-19	Temple University-Of The Commonwealth System Of Higher Education	Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
TW200526626A (en)	2003-09-13	2005-08-16	Astrazeneca Ab	Chemical compounds
AU2004293026B2 (en)	2003-11-21	2012-01-19	Array Biopharma Inc.	AKT protein kinase inhibitors
WO2005063704A1 (en)	2003-12-25	2005-07-14	Ono Pharmaceutical Co., Ltd.	Azetidine ring compounds and drugs comprising the same
WO2005095386A1 (en) *	2004-03-30	2005-10-13	Chiron Corporation	Substituted thiophene derivatives as anti-cancer agents
WO2005117909A2 (en) *	2004-04-23	2005-12-15	Exelixis, Inc.	Kinase modulators and methods of use
MY179032A (en) *	2004-10-25	2020-10-26	Cancer Research Tech Ltd	Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
UY29177A1 (en) *	2004-10-25	2006-05-31	Astex Therapeutics Ltd	SUBSTITUTED DERIVATIVES OF PURINA, PURINONA AND DEAZAPURINA, COMPOSITIONS THAT CONTAIN METHODS FOR THEIR PREPARATION AND ITS USES
AU2005322085B2 (en) *	2004-12-28	2012-07-19	Exelixis, Inc.	[1H-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70S6K, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
FR2880540B1 (en)	2005-01-13	2008-07-11	Aventis Pharma Sa	USE OF PURINE DERIVATIVES AS INHIBITORS OF HSP90 PROTEIN
FR2880626B1 (en)	2005-01-13	2008-04-18	Aventis Pharma Sa	DERIVATIVES OF PURINE, COMPOSITIONS CONTAINING SAME AND USE THEREOF
US7423043B2 (en)	2005-02-18	2008-09-09	Lexicon Pharmaceuticals, Inc.	4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds
US20060281768A1 (en)	2005-06-10	2006-12-14	Gaul Michael D	Thienopyrimidine and thienopyridine kinase modulators
JP5071374B2 (en)	2005-07-14	2012-11-14	アステラス製薬株式会社	Heterocyclic Janus Kinase 3 Inhibitor
US20070049591A1 (en)	2005-08-25	2007-03-01	Kalypsys, Inc.	Inhibitors of MAPK/Erk Kinase
WO2007084667A2 (en)	2006-01-19	2007-07-26	Osi Pharmaceutical, Inc.	Fused heterobicyclic kinase inhibitors
JP2009534454A (en)	2006-04-25	2009-09-24	アステックス、セラピューティックス、リミテッド	Pharmaceutical compounds
EP2037931A2 (en)	2006-04-25	2009-03-25	Astex Therapeutics Limited	Pharmaceutical combinations of pk inhibitors and other active agents
US20090253718A1 (en)	2006-04-25	2009-10-08	Astex Therapeutics Limited	Pharmaceutical Compounds
JP2009534456A (en) *	2006-04-25	2009-09-24	アステックス、セラピューティックス、リミテッド	Pharmaceutical compounds
WO2007125321A2 (en)	2006-04-25	2007-11-08	Astex Therapeutics Limited	Purine and deazapurine derivatives as pharmaceutical compounds
AR064416A1 (en)	2006-12-21	2009-04-01	Cancer Rec Tech Ltd	DERIVATIVES OF PURINE, PIRIDINE AND PYRIMIDINE CONDENSED WITH HETEROCICLES, MODULATORS OF PKA AND / OR PKB, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND USES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES.
AR064415A1 (en)	2006-12-21	2009-04-01	Cancer Rec Tech Ltd	PIRROLO-PIPERIDIN AND PURINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN DISORDERS AND / OR DISEASES MEDIATED BY PKA AND PKB.
WO2008079346A1 (en)	2006-12-21	2008-07-03	Vertex Pharmaceuticals Incorporated	5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
BRPI0818533B8 (en)	2007-10-11	2021-05-25	Astrazeneca Ab	compound, pharmaceutical composition, use of a compound, and, process for preparing a compound

2008
- 2008-10-09 BR BRPI0818533A patent/BRPI0818533B8/en active IP Right Grant
- 2008-10-09 ME MEP-2014-102A patent/ME01999B/en unknown
- 2008-10-09 KR KR1020107010107A patent/KR101494734B1/en active Active
- 2008-10-09 NZ NZ585261A patent/NZ585261A/en unknown
- 2008-10-09 MX MX2010003927A patent/MX2010003927A/en active IP Right Grant
- 2008-10-09 PT PT88067418T patent/PT2201012E/en unknown
- 2008-10-09 SI SI200831281T patent/SI2201012T1/en unknown
- 2008-10-09 PL PL08806741T patent/PL2201012T3/en unknown
- 2008-10-09 HR HRP20140807AT patent/HRP20140807T1/en unknown
- 2008-10-09 AU AU2008309383A patent/AU2008309383B2/en active Active
- 2008-10-09 CN CN200880116651XA patent/CN101861321B/en active Active
- 2008-10-09 MY MYPI2010001617A patent/MY150059A/en unknown
- 2008-10-09 UY UY31384A patent/UY31384A1/en not_active Application Discontinuation
- 2008-10-09 EP EP08806741.8A patent/EP2201012B1/en active Active
- 2008-10-09 WO PCT/GB2008/050925 patent/WO2009047563A1/en not_active Ceased
- 2008-10-09 ES ES08806741.8T patent/ES2522365T3/en active Active
- 2008-10-09 JP JP2010528485A patent/JP4705695B2/en active Active
- 2008-10-09 CA CA2701057A patent/CA2701057C/en active Active
- 2008-10-09 EA EA201000552A patent/EA018512B1/en not_active IP Right Cessation
- 2008-10-09 DK DK08806741.8T patent/DK2201012T3/en active
- 2008-10-09 RS RS20140457A patent/RS53552B1/en unknown
- 2008-10-09 TW TW097139021A patent/TWI453021B/en active
- 2008-10-10 PE PE2012002041A patent/PE20130152A1/en not_active Application Discontinuation
- 2008-10-10 AR ARP080104450A patent/AR068846A1/en active IP Right Grant
- 2008-10-10 US US12/249,477 patent/US8101623B2/en active Active
- 2008-10-10 PE PE2008001748A patent/PE20090964A1/en active IP Right Grant
- 2008-10-10 CL CL2008003023A patent/CL2008003023A1/en unknown
- 2008-10-11 SA SA8290625A patent/SA08290625B1/en unknown
2010
- 2010-03-25 IL IL204721A patent/IL204721A/en active IP Right Grant
- 2010-03-31 ZA ZA2010/02318A patent/ZA201002318B/en unknown
- 2010-04-09 NI NI201000050A patent/NI201000050A/en unknown
- 2010-04-09 DO DO2010000103A patent/DOP2010000103A/en unknown
- 2010-04-09 GT GT201000082A patent/GT201000082A/en unknown
- 2010-04-09 HN HN2010000653A patent/HN2010000653A/en unknown
- 2010-04-09 CU CU20100062A patent/CU23886B1/en active IP Right Grant
- 2010-04-09 CR CR11359A patent/CR11359A/en unknown
- 2010-05-06 CO CO10054272A patent/CO6270328A2/en active IP Right Grant
2011
- 2011-03-09 JP JP2011051117A patent/JP5330430B2/en active Active
- 2011-12-13 US US13/324,191 patent/US20120190679A1/en not_active Abandoned
2014
- 2014-08-28 CY CY20141100689T patent/CY1116929T1/en unknown
2015
- 2015-02-19 US US14/626,303 patent/US9492453B2/en active Active
2016
- 2016-11-15 US US15/351,481 patent/US10059714B2/en active Active
2018
- 2018-07-06 US US16/028,979 patent/US10654855B2/en active Active
2020
- 2020-04-07 US US16/841,820 patent/US11236095B2/en active Active
2021
- 2021-12-16 US US17/644,654 patent/US11760760B2/en active Active
2023
- 2023-08-04 US US18/365,286 patent/US12252495B2/en active Active
2024
- 2024-11-12 HU HUS2400038C patent/HUS2400038I1/en unknown
- 2024-11-12 FI FIC20240039C patent/FIC20240039I1/en unknown
- 2024-11-12 NL NL301299C patent/NL301299I2/en unknown
- 2024-11-13 LT LTPA2024532C patent/LTC2201012I2/lt unknown
- 2024-11-18 NO NO2024050C patent/NO2024050I1/en unknown
- 2024-11-18 CY CY2024030C patent/CY2024030I2/en unknown
- 2024-12-02 FR FR24C1046C patent/FR24C1046I2/en active Active

Also Published As

Publication number	Publication date
EP2201012A1 (en)	2010-06-30
US8101623B2 (en)	2012-01-24
AR068846A1 (en)	2009-12-09
NL301299I2 (en)	2024-12-11
JP4705695B2 (en)	2011-06-22
IL204721A0 (en)	2010-11-30
BRPI0818533A2 (en)	2017-06-06
US11236095B2 (en)	2022-02-01
US11760760B2 (en)	2023-09-19
IL204721A (en)	2013-10-31
HUS2400038I1 (en)	2024-12-28
CU23886B1 (en)	2013-04-19
CU20100062A7 (en)	2011-10-05
JP2011500547A (en)	2011-01-06
MX2010003927A (en)	2010-04-30
CY2024030I1 (en)	2026-02-25
PL2201012T3 (en)	2014-11-28
EA201000552A1 (en)	2010-12-30
US20220220116A1 (en)	2022-07-14
NO2024050I1 (en)	2024-11-18
US10059714B2 (en)	2018-08-28
CA2701057C (en)	2015-03-24
DOP2010000103A (en)	2010-05-31
CN101861321A (en)	2010-10-13
CL2008003023A1 (en)	2009-11-27
CA2701057A1 (en)	2009-04-16
US20090163524A1 (en)	2009-06-25
JP5330430B2 (en)	2013-10-30
FR24C1046I2 (en)	2025-10-10
US20120190679A1 (en)	2012-07-26
DK2201012T3 (en)	2014-09-08
LTPA2024532I1 (en)	2024-12-10
CO6270328A2 (en)	2011-04-20
SI2201012T1 (en)	2014-10-30
US20170057969A1 (en)	2017-03-02
KR20100101077A (en)	2010-09-16
RS53552B1 (en)	2015-02-27
NI201000050A (en)	2011-12-22
US20180312516A1 (en)	2018-11-01
AU2008309383A1 (en)	2009-04-16
SA08290625B1 (en)	2012-02-12
FIC20240039I1 (en)	2024-11-12
PT2201012E (en)	2014-09-04
US12252495B2 (en)	2025-03-18
MY150059A (en)	2013-11-29
KR101494734B1 (en)	2015-02-26
NZ585261A (en)	2011-10-28
US9492453B2 (en)	2016-11-15
GT201000082A (en)	2015-03-10
CR11359A (en)	2010-07-15
ES2522365T3 (en)	2014-11-14
AU2008309383B2 (en)	2012-04-19
CY1116929T1 (en)	2017-04-05
ZA201002318B (en)	2012-09-26
PE20090964A1 (en)	2009-08-15
PE20130152A1 (en)	2013-03-17
UY31384A1 (en)	2009-05-29
JP2011157364A (en)	2011-08-18
TW200927128A (en)	2009-07-01
US20150182531A1 (en)	2015-07-02
US20240109902A1 (en)	2024-04-04
CY2024030I2 (en)	2026-02-25
HK1143154A1 (en)	2010-12-24
WO2009047563A1 (en)	2009-04-16
HN2010000653A (en)	2013-03-18
BRPI0818533B8 (en)	2021-05-25
ME01999B (en)	2015-05-20
EA018512B1 (en)	2013-08-30
TWI453021B (en)	2014-09-21
US20200239483A1 (en)	2020-07-30
CN101861321B (en)	2013-02-06
BRPI0818533B1 (en)	2020-12-01
US10654855B2 (en)	2020-05-19
FR24C1046I1 (en)	2025-01-10
EP2201012B1 (en)	2014-06-25
HRP20140807T1 (en)	2014-11-21

Publication	Publication Date	Title
CN300728676S (zh)	2008-01-09	旅行包(12)
CN300728875S (zh)	2008-01-09	椅子(38)
CN300727351S (zh)	2008-01-02	摩托车(426)
CN300726938S (zh)	2008-01-02	包装盒
CN300860887S (zh)	2008-12-17	剪刀(0709)
CN300781310S (zh)	2008-05-21	伸缩旗杆
CN300728994S (zh)	2008-01-09	床头(3)
CN300726987S (zh)	2008-01-02	包装盒(双氯芬酸钠)
CN300879928S (zh)	2009-02-04	袜子(qy113)
CN300747999S (zh)	2008-02-20	车载发射器(fm21)
CN300729590S (zh)	2008-01-09	包装袋(哺乳猪配合颗粒饲料)
CN300915490S (zh)	2009-04-29	包装用隔板
CN300729928S (zh)	2008-01-09	蓄电池盒(6-dzm-12b)
CN300727571S (zh)	2008-01-02	耳机
CN300728429S (zh)	2008-01-02	Led投光灯(lve-f480-48rgb\方型)
CN300765575S (zh)	2008-04-16	电烤箱(07-4)
CN300796351S (zh)	2008-06-25	搅拌机(kd-b20)
CN300816755S (zh)	2008-08-13	台灯灯座(736)
CN300730360S (zh)	2008-01-09	店牌
CN300729639S (zh)	2008-01-09	电子手表(mp4-s808型)
CN300729898S (zh)	2008-01-09	电动车轮毂(五星前轮)
CN300764805S (zh)	2008-04-09	酸奶机
CN300789262S (zh)	2008-06-11	沙发
CN300726846S (zh)	2008-01-02	酒瓶(清样)
CN300728124S (zh)	2008-01-02	宝剑(秦皇宝剑)